Emma Hall

Has grant

Institute of Cancer Research

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

CRUK/14/038 CORE: A randomised trial of conventional care versus radioablation (stereotactic body radiotherapy)for extracranial metastases

Open Date: 2015-11-01

Close Date: 2020-10-31

Grant: Close

CRUK/14/024: HYPO-RT-PC trial - Randomised Phase III study of HYPO-fractionated Radiotherapy in Localised Prostate cancer

Open Date: 2014-12-01

Close Date: 2020-08-31

Grant: Close

A phase II randomised feasibility study of Chemoresection and surgicAl management in Low rIsk non muscle invasive Bladder cancER (CALIBER)

Open Date: 2014-10-01

Close Date: 2017-09-30

Grant: Close

A phase II randomised feasibility study of Chemoresection and surgicAl management in Low rIsk non muscle invasive Bladder cancER (CALIBER)

Open Date: 2014-10-01

Close Date: 2017-09-30

Grant: Close

A phase II randomised feasibility study of Chemoresection and surgicAl management in Low rIsk non muscle invasive Bladder cancER (CALIBER)

Open Date: 2014-10-01

Close Date: 2017-09-30

Articles (17)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Collaborators (18)

Robert Jones

University of Glasgow

UNITED KINGDOM

View details

Louise Murray

Associate Professor and Honorary Consultant Clinical Oncologist

UNITED KINGDOM

View details

Björn Hansen

Danderyd University Hospital

SWEDEN

View details

Douglas Brand

University College London

UNITED KINGDOM

View details

Teresa Ullberg

Lund University

SWEDEN

View details

Pratik Samant

University of Oxford

UNITED KINGDOM

View details

Wei Shen Tan

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Stephen Rice

Newcastle University

UNITED KINGDOM

View details

Richard Adams

Professor

Cardiff University

UNITED KINGDOM

View details

Frank Van den Heuvel

University of Oxford

UNITED KINGDOM

View details

Samantha Hinsley

University of Glasgow

UNITED KINGDOM

View details

Ashish Kamat

Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Fay Cafferty

University College London

UNITED KINGDOM

View details

Anna Wilkins

Institute of Cancer Research

UNITED KINGDOM

View details

Ge Yu

Senior Lecturer in Health Economics and Econometrics

King’s College London

UNITED KINGDOM

View details

Chris Hurt

Cardiff University School of Medicine

UNITED KINGDOM

View details

Steven Penegar

Institute of Cancer Research

UNITED KINGDOM

View details

Robert Adam Mitchell

Head of MR-linac Physics

Royal Marsden Hospital Sutton

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Emma Hall

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (17)

Influence of Comorbidity on Endovascular Thrombectomy Outcomes for Medium‐Vessel Occlusion Stroke: A Nationwide Prospective Observational Study

ESTRO guidelines for developing questionnaires in survey-based radiation oncology research

Impact of on-trial IGRT quality assurance in an international adaptive radiotherapy trial for participants with bladder cancer

Reply to P. de Boissieu et al

“Why am I still suffering?”: Experience of long-term fatigue and neurocognitive changes in oropharyngeal cancer survivors following (chemo)radiotherapy

MRI-guided radiotherapy in twenty fractions for localised prostate cancer; results from the MOMENTUM study

International Society of Urological Pathology (ISUP) Gleason Grade Groups stratify outcomes in the CHHiP Phase 3 prostate radiotherapy trial

A Personalized Clinical Dynamic Prediction Model to Characterize Prognosis for Patients With Localized Prostate Cancer: Analysis of the CHHiP Phase 3 Trial

Clinical trial design for non-muscle-invasive bladder cancer

Machine learning for normal tissue complication probability prediction: Predictive power with versatility and easy implementation

The Association between Acute and Late Genitourinary and Gastrointestinal Toxicities: An Analysis of the PACE B Study

Differences in quality of life and toxicity for male and female patients following chemo (radiotherapy) for bladder cancer

Photodynamic Diagnosis-guided Transurethral Resection of Bladder Tumour in Participants with a First Suspected Diagnosis of Intermediate- or High-risk Non–muscle-invasive Bladder Cancer: Cost-effectiveness Analysis Alongside a Randomised Controlled Trial

A Road Map for Designing Phase I Clinical Trials of Radiotherapy–Novel Agent Combinations

Outcomes in Patients with Muscle-invasive Bladder Cancer Treated with Neoadjuvant Chemotherapy Followed by (Chemo)radiotherapy in the BC2001 Trial

Intermittent schedules of the oral RAF-MEK inhibitor CH5126766/VS-6766 in patients with RAS/RAF-mutant solid tumours and multiple myeloma: a single-centre, open-label, phase 1 dose-escalation and basket dose-expansion study.

Life After COVID-19 for Cancer Clinical Trials.

Collaborators (18)

Robert Jones

Louise Murray

Björn Hansen

Douglas Brand

Teresa Ullberg

Pratik Samant

Wei Shen Tan

Stephen Rice

Richard Adams

Frank Van den Heuvel

Samantha Hinsley

Ashish Kamat

Fay Cafferty

Anna Wilkins

Ge Yu

Chris Hurt

Steven Penegar

Robert Adam Mitchell

Make your next move.